Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience

被引：2
|
作者：
Adisen, Esra [1 ]
Oztas, Murat Orhan [1 ]
Aksakal, Ahmet Burhan [1 ]
ilter, Nilsel [1 ]
Gulekon, Ayla [1 ]
机构：
[1] Gazi Univ, Fac Med, Dept Dermatol, Ankara, Turkiye
来源：
ANAIS BRASILEIROS DE DERMATOLOGIA | 2023年 / 98卷 / 02期
关键词：
THERAPY;
D O I：
10.1016/j.abd.2022.06.003
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：240 / 242
页数：3
相关论文
共 50 条
  • [31] Apremilast in patients with history of malignancy: a real-life, single-center experience
    Di Lernia, Vito
    Casanova, Dahiana M.
    Ricci, Cinzia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (01) : E22 - E24
  • [32] Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience
    Antonioli, Elisabetta
    Staderini, Michela
    Pilerci, Sofia
    Perfetto, Federico
    Cappelli, Francesco
    Allinovi, Marco
    Nozzoli, Chiara
    Attucci, Irene
    Buzzichelli, Alessandra
    Messeri, Maria
    Bosi, Alberto
    LEUKEMIA & LYMPHOMA, 2020, 61 (13) : 3255 - 3258
  • [33] Effectiveness of Omalizumab in Patients with Chronic Inducible Urticaria: real-life experience from two UCARE centres
    Can, P. K.
    Salman, A.
    Hosgoren-Tekin, S.
    Kocaturk, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) : E679 - E682
  • [34] Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America
    Cherrez-Ojeda, Ivan
    Maurer, Marcus
    Bernstein, Jonathan A.
    Vanegas, Emanuel
    Felix, Miguel
    Ramon, German D.
    Ensina, Luis Felipe
    Larco Sousa, Jose Ignacio
    Matos Benavides, Edgar Emilio
    Cardona Villa, R.
    Staffeld, P. Latour
    Maria Morfin-Maciel, Blanca
    Mori, Jose
    Wilches C, Paul
    Mata, Valeria L.
    Cherrez, Annia
    WORLD ALLERGY ORGANIZATION JOURNAL, 2019, 12 (02):
  • [35] A SINGLE-CENTER REAL-LIFE EXPERIENCE WITH BELANTAMAB MAFODOTIN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Condorelli, A.
    Garibaldi, B.
    Gagliano, C.
    Romano, A.
    Ragusa, M.
    Del Fabro, V.
    Parrinello, N. L.
    Longo, A.
    Cosentino, S.
    Di Raimondo, F.
    Conticello, C.
    HAEMATOLOGICA, 2021, 106 (10) : 169 - 169
  • [36] Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
    Turk, Murat
    Yilmaz, Insu
    Bahcecioglu, Sakine Nazik
    ALLERGOLOGY INTERNATIONAL, 2018, 67 (01) : 85 - 89
  • [37] Real-Life Clinical Practice with Sorafenib in Advance Hepatocellular Carcinoma: A Single-Center Experience Second Analysis
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Iwanishi, Mina
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Ida, Hiroshi
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kitano, Masayuki
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2015, 33 (06) : 728 - 734
  • [38] Treatment and retreatment with omalizumab in chronic spontaneous urticaria: real life experience with twenty-five patients
    Turk, M.
    Yilmaz, I
    Bahcecioglu, Nazik S.
    ALLERGY, 2017, 72 : 719 - 720
  • [39] Omalizumab in chronic inducible urticaria: A retrospective, real-life study
    Fialek, M.
    Dezoteux, F.
    Le Moinga, A.
    Karimova, E.
    Ramdane, N.
    Pape, E.
    Azib-Meftah, S.
    Staumont-Salle, D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2021, 148 (04): : 262 - 265
  • [40] Real-life data on the effectiveness and safety of omalizumab in adolescents with chronic spontaneous urticaria: A retrospective study
    Guarracino, C.
    Tomasoni, A.
    Marseglia, A.
    Marseglia, G. L.
    Licari, A.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 : 79 - 79
12345